PRAVEEN MOOLAMALLA
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- Fairview, TX
- NPI
- 1114935954
- Received
- $5,915 in 341 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 56 | $1,164 |
| 2024 | General payment | 39 | $768 |
| 2023 | General payment | 43 | $795 |
| 2022 | General payment | 40 | $676 |
| 2021 | General payment | 57 | $899 |
| 2020 | General payment | 19 | $360 |
| 2019 | General payment | 87 | $1,249 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 82 | $1,311 | 2021–2025 |
| Otsuka America Pharmaceutical, Inc. | 45 | $862 | 2019–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $719 | 2019–2025 |
| Sunovion Pharmaceuticals Inc. | 39 | $667 | 2019–2022 |
| Lundbeck LLC | 22 | $438 | 2019–2025 |
| Vanda Pharmaceuticals Inc. | 15 | $276 | 2019–2025 |
| E.R. Squibb & Sons, L.L.C. | 13 | $260 | 2025 |
| Merck Sharp & Dohme LLC | 10 | $187 | 2019–2023 |
| Alkermes, Inc. | 9 | $182 | 2022–2025 |
| Allergan, Inc. | 20 | $182 | 2019 |
| Shire North American Group Inc | 9 | $128 | 2019 |
| Validus Pharmaceuticals LLC | 6 | $124 | 2019–2024 |
| Supernus Pharmaceuticals, Inc. | 5 | $109 | 2024–2025 |
| Janssen Pharmaceuticals, Inc | 6 | $89 | 2019–2021 |
| Avanir Pharmaceuticals, Inc. | 5 | $72 | 2019 |
| Orexo US, Inc. | 4 | $56 | 2019 |
| Currax Pharmaceuticals LLC | 4 | $51 | 2021–2022 |
| Biohaven Pharmaceuticals, Inc. | 1 | $49 | 2021 |
| Neos Therapeutics, LP | 3 | $43 | 2019–2025 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 | 2019 |
| Adlon Therapeutics L.P. | 1 | $18 | 2019 |
| Antares Pharma, Inc. | 1 | $17 | 2019 |
| Vertical Pharmaceuticals, LLC | 1 | $16 | 2019 |
| Bausch Health US, LLC | 1 | $14 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 341 | $5,915 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | E.R. Squibb & Sons, L.L.C. | $27 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-11 | Vanda Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-05 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-12-01 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-24 | Neos Therapeutics, LP | $13 | Food and Beverage | Cash or cash equivalent | Adzenys XR-ODT Drug, ADHD | 2025 | |
| 2025-11-19 | E.R. Squibb & Sons, L.L.C. | $36 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-14 | Vanda Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-10 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-11-05 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-03 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-22 | E.R. Squibb & Sons, L.L.C. | $8 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-20 | Supernus Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-10-15 | Vanda Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-13 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-10-08 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-25 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-09-17 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-15 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-08 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-04 | Takeda Pharmaceuticals U.S.A., Inc. | $15 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-08-18 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-13 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-11 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-28 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-23 | Supernus Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-21 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-14 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-07 | Alkermes, Inc. | $16 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-07-02 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-02 | E.R. Squibb & Sons, L.L.C. | $3 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-01 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-06-19 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-16 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-04 | Vanda Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-05-28 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-05-15 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-12 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-07 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-23 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-04-15 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-07 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-20 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-19 | E.R. Squibb & Sons, L.L.C. | $26 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-10 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-27 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-26 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-19 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-10 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-05 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-29 | Lundbeck LLC | $27 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-23 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-20 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-15 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-06 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-12-04 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-14 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-28 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-23 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-17 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-23 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-16 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-29 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-26 | Takeda Pharmaceuticals U.S.A., Inc. | $15 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-08-14 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-09 | Lundbeck LLC | $28 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-05 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-05 | Otsuka America Pharmaceutical, Inc. | $1 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-07-25 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-17 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-10 | Takeda Pharmaceuticals U.S.A., Inc. | $20 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-07-08 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-06-24 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-06-13 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-06-03 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-05-29 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-05-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-13 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-29 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-25 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-22 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-15 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-21 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-03-20 | Otsuka America Pharmaceutical, Inc. | $26 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-18 | Validus Pharmaceuticals LLC | $16 | Food and Beverage | Cash or cash equivalent | Equetro Drug, CNS | 2024 | |
| 2024-03-11 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-26 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-19 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-15 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-02-07 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-01-29 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-17 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-01-08 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2023-12-13 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2023 | |
| 2023-12-13 | Takeda Pharmaceuticals U.S.A., Inc. | $12 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2023 | |
| 2023-12-11 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-06 | Lundbeck LLC | $26 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-11-15 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-30 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-26 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-16 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-11 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2023 | |
| 2023-10-03 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-26 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-09-26 | Lundbeck LLC | $3 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-09-12 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-17 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2023 | |
| 2023-08-14 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-10 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-08-07 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-31 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-07-27 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2023 | |
| 2023-07-20 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-10 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-06-29 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-06-15 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-06-12 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-07 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-06 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-05-15 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-27 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2023 | |
| 2023-04-24 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-05 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-03-30 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-03-30 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-23 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-01 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-27 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2023 | |
| 2023-02-13 | Lundbeck LLC | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-02-08 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-07 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-01-23 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-01-19 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2023 | |
| 2023-01-11 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-05 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-04 | Validus Pharmaceuticals LLC | $19 | Food and Beverage | Cash or cash equivalent | Equetro Drug, CNS | 2023 | |
| 2022-11-22 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-11-10 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2022 | |
| 2022-11-02 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-11-01 | Currax Pharmaceuticals LLC | $13 | Food and Beverage | In-kind items and services | CONTRAVE Drug, Obesity | 2022 | |
| 2022-10-13 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-10-12 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-09-28 | Validus Pharmaceuticals LLC | $33 | Food and Beverage | Cash or cash equivalent | Equetro Drug, CNS | 2022 | |
| 2022-09-20 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-08-18 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-08-17 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-08-10 | Sunovion Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-08-01 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-07-25 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2022 | |
| 2022-07-25 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-07-20 | Sunovion Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-06-13 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-06-08 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-05-19 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-05-18 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2022 | |
| 2022-05-18 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-21 | Currax Pharmaceuticals LLC | $14 | Food and Beverage | In-kind items and services | CONTRAVE Drug, Obesity | 2022 | |
| 2022-04-20 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2022 | |
| 2022-04-14 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-04-06 | Sunovion Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-04-04 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-22 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-17 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-15 | Sunovion Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-03-14 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2022 | |
| 2022-02-22 | Sunovion Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-02-16 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2022 | |
| 2022-02-14 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-02-09 | Sunovion Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-02-07 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-02-02 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-01-19 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-01-19 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-01-06 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2022 | |
| 2022-01-04 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-01-03 | Sunovion Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2021-12-15 | Takeda Pharmaceuticals U.S.A., Inc. | $20 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2021 | |
| 2021-12-07 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-12-01 | Sunovion Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 | |
| 2021-11-17 | Sunovion Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 | |
| 2021-11-11 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-11-10 | Takeda Pharmaceuticals U.S.A., Inc. | $15 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2021 | |
| 2021-11-01 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2021 | |
| 2021-10-25 | Sunovion Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 | |
| 2021-10-04 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2021 | |
| 2021-09-29 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-27 | Sunovion Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2021 | |
| 2021-09-23 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-13 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | BRINTELLIX Drug, PSYCHIATRY | 2021 | |
| 2021-09-09 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-09-02 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2021 | |
| 2021-09-02 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-01 | Currax Pharmaceuticals LLC | $11 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2021 | |
| 2021-08-26 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | BRINTELLIX Drug, PSYCHIATRY | 2021 | |
| 2021-08-25 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-08-19 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-08-16 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2021 | |
| 2021-08-11 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2021 |
The latest 200 records of 341.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Fairview, TX, county Collin County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Fairview, TX | County Collin County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 10,783 | 1,163,337 | 30,188,424 |
| Population, 2020 census P1 | 10,372 | 1,064,465 | 29,145,505 |
| Median age B01002 | 49.1 | 37.3 | 35.6 |
| Under 18 B01001 | 22.7% | 24.7% | 25.0% |
| 65 and over B01001 | 30.1% | 11.6% | 13.4% |
| Households B11001 | 4,211 | 416,646 | 10,992,816 |
| Foreign born B05002 | 8.4% | 23.3% | 17.6% |
| Median household income B19013 | $109,347 | $121,600 | $78,476 |
| Median family income B19113 | $137,336 | $145,862 | $94,599 |
| Per capita income B19301 | $62,345 | $57,056 | $40,752 |
| Poverty rate B17001 | 14.8% | 6.2% | 13.8% |
| Unemployment rate B23025 | 4.4% | 4.2% | 5.3% |
| Civilian labor force B23025 | 3,973 | 642,253 | 15,233,563 |
| Mean commute (minutes) B08013 | 33.8 | 28.2 | 26.7 |
| Bachelor's degree or higher B15003 | 59.4% | 56.2% | 33.8% |
| Housing units B25001 | 4,552 | 437,396 | 12,128,515 |
| Owner-occupied B25003 | 73.9% | 64.5% | 62.6% |
| Renters B25003 | 26.1% | 35.5% | 37.4% |
| Median home value B25077 | $597,300 | $475,600 | $283,800 |
| Median gross rent B25064 | $1,947 | $1,859 | $1,403 |
| White, not Hispanic B03002 | 73.9% | 49.6% | 39.1% |
| Black B03002 | 10.3% | 10.8% | 11.9% |
| Hispanic or Latino B03002 | 7.4% | 16.1% | 39.7% |
| Asian B03002 | 4.0% | 18.7% | 5.5% |
| American Indian and Alaska Native B03002 | 0.3% | 0.2% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Fairview, TX.
Comments